Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MLAB Mesa Laboratories Inc
- Stocks
- Technology
- NASDAQ: MLAB
Price (delayed)
$122.42
Market cap
$665.18M
P/E Ratio
N/A
Dividend/share
$0.64
EPS
-$46.31
Enterprise value
$829.94M
Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries.
Highlights
The debt has contracted by 16% YoY and by 4.5% from the previous quarter
The gross profit has grown by 15% YoY and by 4.5% from the previous quarter
The company's quick ratio has shrunk by 69% YoY but it rose by 7% QoQ
MLAB's equity has dropped by 61% year-on-year and by 3.9% since the previous quarter
Key stats
What are the main financial stats of MLAB
Market
Valuations
Earnings
Shares outstanding
5.43M
Market cap
$665.18M
Enterprise value
$829.94M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.28
Price to sales (P/S)
2.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.49
Revenue
$237.75M
Gross profit
$149.01M
Operating income
-$257.29M
Net income
-$249.44M
EBIT
-$259.24M
EBITDA
-$235.92M
Free cash flow
$43M
Per share
Balance sheet
Liquidity
EPS
-$46.31
EPS diluted
-$46.32
Free cash flow per share
$7.92
Book value per share
$28.58
Revenue per share
$43.79
TBVPS
$29.81
Total assets
$437.15M
Total liabilities
$281.93M
Debt
$195.72M
Equity
$155.21M
Working capital
-$45.03M
Debt to equity
1.26
Current ratio
0.71
Quick ratio
0.45
Net debt/EBITDA
-0.7
Margins
Efficiency
Dividend
EBITDA margin
-99.2%
Gross margin
62.7%
Net margin
-104.9%
Operating margin
-108.2%
Return on assets
-56.1%
Return on equity
-162.8%
Return on invested capital
-110.1%
Return on capital employed
-92.2%
Return on sales
-109%
Dividend yield
0.52%
DPS
$0.64
Payout ratio
N/A
MLAB stock price
How has the Mesa Laboratories stock price performed over time
Intraday
0.88%
1 week
-1.15%
1 month
8.41%
1 year
1.5%
YTD
-7.17%
QTD
3.17%
Financial performance
How have Mesa Laboratories's revenue and profit performed over time
Revenue
$237.75M
Gross profit
$149.01M
Operating income
-$257.29M
Net income
-$249.44M
Gross margin
62.7%
Net margin
-104.9%
The gross profit has grown by 15% YoY and by 4.5% from the previous quarter
MLAB's revenue is up by 12% year-on-year and by 4.1% since the previous quarter
The operating margin has grown by 6% from the previous quarter
The net margin has grown by 2.5% from the previous quarter
Price vs fundamentals
How does MLAB's price correlate with its fundamentals
Growth
What is Mesa Laboratories's growth rate over time
Valuation
What is Mesa Laboratories stock price valuation
P/E
N/A
P/B
4.28
P/S
2.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.49
MLAB's equity has dropped by 61% year-on-year and by 3.9% since the previous quarter
MLAB's price to book (P/B) is 43% more than its 5-year quarterly average of 3.0 and 7% more than its last 4 quarters average of 4.0
The P/S is 53% below the 5-year quarterly average of 6.0 but 3.7% above the last 4 quarters average of 2.7
MLAB's revenue is up by 12% year-on-year and by 4.1% since the previous quarter
Efficiency
How efficient is Mesa Laboratories business performance
MLAB's return on equity is down by 43% since the previous quarter
The return on assets has declined by 19% since the previous quarter
Mesa Laboratories's return on invested capital has decreased by 18% QoQ
The company's return on sales rose by 2.8% QoQ
Dividends
What is MLAB's dividend history
DPS
$0.64
Dividend yield
0.52%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 55% more than its total liabilities
MLAB's current ratio has dropped by 74% year-on-year
The company's quick ratio has shrunk by 69% YoY but it rose by 7% QoQ
The debt is 26% more than the equity
MLAB's debt to equity has soared by 117% YoY
MLAB's equity has dropped by 61% year-on-year and by 3.9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.